204 filings
Page 6 of 11
8-K
m8061ju4q0e
25 Apr 06
Entry into a Material Definitive Agreement
12:00am
8-K
qjvbaf57ooe6 uv
21 Apr 06
OSI Pharmaceuticals Announces Three Additions to Its 2006 Board of Director Slate
12:00am
8-K
u7v4kcfwgwc6r
18 Apr 06
OSI Pharmaceuticals Announces Submission of New Drug Application for Tarcevaâ in Japan
12:00am
8-K
bxfu7q k007k4t
12 Apr 06
Other Events
12:00am
8-K
lsryle v9y5a
6 Apr 06
OSI Pharmaceuticals IGF-1R Inhibitor Program Featured in 97th Annual Meeting of the American Association of Cancer Research Media Program
12:00am
8-K
2l8lo71w
29 Mar 06
Osi Pharmaceuticals Files Resale Registration Statement for Previously Issued Convertible Notes
12:00am
8-K
trqjeo
8 Mar 06
Osi Pharmaceuticals Announces Year End 2005 Financial Results
12:00am
8-K
bz58ius zza
1 Mar 06
Other Events
12:00am
8-K
2bivve
24 Feb 06
Other Events
12:00am
8-K
6e4ee
13 Feb 06
Entry into a Material Definitive Agreement
12:00am
8-K
wkpyi6s
6 Feb 06
OSI Pharmaceuticals Announces Fourth Quarter Net Sales for Tarceva®’s International Launch
12:00am
8-K
a4j1usfxxw20347ai
11 Jan 06
Other Events
12:00am
8-K
wdp9xz
28 Dec 05
OSI Pharmaceuticals Grants License Under Dipeptidyl Peptidase IV (DPIV) Patents
12:00am
8-K
yh7nuo
21 Dec 05
Unregistered Sales of Equity Securities
12:00am
8-K
sehv0k08i 5xr
16 Dec 05
OSI Announces Proposal to Offer $100 Million of Convertible Senior Subordinated Notes
12:00am
8-K/A
1t5ylh pa
15 Dec 05
Other Events
12:00am
8-K
3w3ni5
14 Dec 05
OSI Announces Signing Of A Commitment Letter For $75 Million Revolving Credit Facility
12:00am
8-K
9bzyggbl0yev
14 Dec 05
Other Events
12:00am
8-K
juiv91 yxp
9 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K/A
dhokih6
9 Dec 05
Financial Statements and Exhibits
12:00am